# Hôpital Cardiologique du Haut-Lévêque

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/hopital-cardiologique-du-haut-leveque/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 64 |
| Citations | 1,098,382 |
| City | Pessac |
| Country | FR |
| Description | Hôpital Cardiologique du Haut-Lévêque is a research organisation in Pessac, FR. OpenAlex records 9,375 works and 1,098,382 citations for it. 1,739 researchers list it as their most recent affiliation. |
| Homepage | https://www.chu-bordeaux.fr/CHU-de-Bordeaux/H%C3%B4pitaux-et-sites-du-CHU/Groupe-hospitalier-Sud/H%C3%B4pital-cardiologique/ |
| OpenAlex ID | https://openalex.org/I4210120975 |
| Researchers | 1,739 |
| ROR ID | https://ror.org/02bf3a828 |
| Type | healthcare |
| Works | 9,375 |

## University papers

- [Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial](https://scholariq.org/papers/pembrolizumab-in-patients-with-advanced-hepatocellular-carcinoma-previously/)
- [Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial](https://scholariq.org/papers/brivanib-as-adjuvant-therapy-to-transarterial-chemoembolization-in-patients-with/)
- [Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma](https://scholariq.org/papers/four-year-overall-survival-update-from-the-phase-iii-himalaya-study-of/)
- [Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study](https://scholariq.org/papers/durvalumab-with-or-without-bevacizumab-with-transarterial-chemoembolisation-in/)

## University top topics

Showing 8 of 25.

- [Cardiac Arrhythmias and Treatments](https://scholariq.org/topics/cardiac-arrhythmias-and-treatments/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)
- [Cardiac electrophysiology and arrhythmias](https://scholariq.org/topics/cardiac-electrophysiology-and-arrhythmias/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.